Prostaglandin E1 New Aspects on Pharmacology, Metabolism and Clinical Efficacy /
Autor Corporativo: | |
---|---|
Otros Autores: | , , |
Formato: | eBook |
Lenguaje: | English |
Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
1991.
|
Edición: | 1st ed. 1991. |
Materias: | |
Acceso en línea: | https://doi.org/10.1007/978-3-642-76910-8 |
Tabla de Contenidos:
- Cellular Sites of Action of Prostaglandins in the Cardiovascular System
- On the Metabolism and Pharmacokinetics of Prostaglandin E1 Administered by Intra-arterial or Intravenous Infusions
- Actions of PGE1 PGE0 and 15-keto-PGE1 on Vessel Tone In Vitro
- 13,14-dihydro-PGE1 (PGE0) but not 15-keto-PGE1 is a Potent Inhibitor of Human Platelet and Neutrophil Activation
- Comparable Inhibitory Action of PGE1 and 13–14-dihydro-PGE1 on Smooth Muscle Cell Activity and Extracellular Matrix Production
- PGE1 and 13,14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism
- Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease
- A Comparison of Different Dosages of Intra-arterial and Intravenous Administered Prostaglandin E1 in Healthy Volunteers
- Transcutaneous Oxygen Pressure at Different Dosages of Intravenous Prostaglandin E1 in Patients with Severe Arterial Occlusive Disease: A Double-Blind, Placebo-Controlled Study
- Transcutaneous PO2 During Intra-arterial and Intravenous PGE1 Infusion in Patients with Critical Limb Ischaemia
- Effects of Intravenous PGE1 on Blood Flow and Microcirculation: A Double-Blind, Placebo-Controlled Study in Patients with Critical Limb Ischaemia
- Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication
- Adjuvant Intravenous PGE1 Treatment After Profundaplasty for Limb Salvage.